Biotech Values

[AlpineBV_Miller]

Dr. Richard Chin - Top Ten Intellectual Optical Illusions in Clinical Research

I hope this is not too promotional (Dew, no hard feelings if you delete it for being so), but I believe the content of the interview with Dr. Chin is high enough quality to be worthwhile to the board.

http://www.youtube.com/user/BiotechStockResearch

Richard Chin is the CEO of The Institute for OneWorld Health, a non-profit biotech that develops medicines for treating diseases afflicting the developing world.

Dr. Chin has overseen over 45 Investigational New Drug (IND) Applications for new molecular entities and new indications, as well as eleven drug registrations.

He was the Senior VP and Head of Global Development at Elan Corporation, where he had worldwide responsibility for Clinical Development, Regulatory, Biostatistics, CMC, QA/Compliance, Safety and Medical Affairs. Dr. Chin has also held various clinical and scientific roles for Genentech, Inc. including Head of Clinical Research for the Biotherapeutics Unit, overseeing approximately half of the drugs at Genentech. He began his career at Procter and Gamble Pharmaceuticals, where he served as Associate Medical Director.

Dr. Chin holds the equivalent of a J.D. with honors from Oxford University in England under a Rhodes Scholarship. Dr. Chin holds a Medical Degree from Harvard Medical School and is licensed to practice medicine in California.